{"organizations": [], "uuid": "437b1ad9ef79aeee09ba837b9380ac9d1a29d3d7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180305.html", "section_title": "Archive News &amp; Video for Monday, 05 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-sorrento-says-its-car-t-cell-thera/brief-sorrento-says-its-car-t-cell-therapy-showed-therapeutic-activity-in-stage-iv-pancreas-cancer-in-early-stage-trial-idUSASB0C8R7", "country": "US", "domain_rank": 408, "title": "BRIEF-Sorrento Says Its CAR-T Cell Therapy Showed Therapeutic Activity In Stage IV Pancreas Cancer In Early Stage Trial", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.025, "site_type": "news", "published": "2018-03-05T21:21:00.000+02:00", "replies_count": 0, "uuid": "437b1ad9ef79aeee09ba837b9380ac9d1a29d3d7"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-sorrento-says-its-car-t-cell-thera/brief-sorrento-says-its-car-t-cell-therapy-showed-therapeutic-activity-in-stage-iv-pancreas-cancer-in-early-stage-trial-idUSASB0C8R7", "ord_in_thread": 0, "title": "BRIEF-Sorrento Says Its CAR-T Cell Therapy Showed Therapeutic Activity In Stage IV Pancreas Cancer In Early Stage Trial", "locations": [], "entities": {"persons": [{"name": "sorrento", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "sorrento therapeutics inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 5 (Reuters) - Sorrento Therapeutics Inc:\n* SORRENTO THERAPEUTICS AUTOLOGOUS ANTI-CEA CAR-T CELL THERAPY FOR LIVER METASTASES DEMONSTRATES THERAPEUTIC ACTIVITY IN STAGE IV PANCREAS CANCER IN A PHASE 1B HITM-SURE TRIAL (NCT02850536) Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-05T21:21:00.000+02:00", "crawled": "2018-03-06T22:36:37.011+02:00", "highlightTitle": ""}